Regeneron Pharmaceuticals, Inc. and Sanofi announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment...
Pharma major Lupin announced the successful completion of an inspection carried out by the US FDA at its Nagpur facility....
Kite, a Gilead Company announced it has leased a new facility in the Netherlands to engineer cell therapies in Europe....
Gilead Sciences, Inc. announced that the U.S. FDA has approved once-daily oral Truvada® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in...
Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
UCB announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab...
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional therapeutics, and Daiichi Sankyo Company, Limited announced that they entered into...
Eli Lilly and Company announced that new results from a number of studies across the company's oncology product and pipeline...
Takeda Pharmaceutical Company Limited announced that the company will feature a total of 14 Takeda Oncology-sponsored presentations at two upcoming...
Celgene Corporation announced that data from more than 60 company-sponsored, cooperative group and investigator-initiated clinical studies evaluating Celgene agents will...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
